Foundation for Angelman Syndrome Therapeutics Enters Partnership with Rush University for Research Center
The Foundation for Angelman Syndrome Therapeutics (FAST) recently entered a partnership with Rush University in order to establish a clinical trial and translational research center for rare neurodevelopmental disorders.…